Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Valeant Pharmaceuticals International published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-11 of 11
» View wsbtradio.com items only
    May 16, 2013 |Story| Reuters

  1. Novartis says has no intention of buying Actavis

    Reuters
    ZURICH (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday. "We have no intention to pursue them," spokesman Eric...

    Tags: Novartis AG, The Wall Street Journal

    2. May 14, 2013 |Story| Reuters

  2. Actavis rejected $15 billion offer from Mylan: source

    Reuters
    NEW YORK (Reuters) - Actavis Inc received and rejected a takeover offer from Mylan Inc last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation told Reuters on Tuesday. Mylan's cash and stock bid for...

    Tags: NYSE Euronext, Inc., Stock Market, Pharmaceuticals, Chemical Industry

    3. May 2, 2013 |Story| Reuters

  3. CANADA STOCKS-TSX may open higher as ECB cuts interest rates

    Reuters
    May 2 (Reuters) - Canada's main stock index is set to open higher after the European Central Bank cut interest rates by 25 basis points as inflation in the euro zone fell below its target. TOP STORIES * The European Central Bank cut interest rates for...

    Tags: Central Bank, Manulife Financial Corporation, Thomson Corporation, Gildan Activewear Incorporated, Weather

    4. May 2, 2013 |Story| Reuters

  4. Valeant posts bigger loss as costs rise

    Reuters
    May 2 (Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest publicly traded drugmaker, reported a bigger first-quarter loss as expenses rose due to its $2.6 billion acquisition of Medicis Pharmaceuticals Corp. The company's net loss...

    Tags: Drugs and Medicines, Medicis Pharmaceutical Corporation

    5. May 1, 2013 |Story| Reuters

  5. Deals of the day -- mergers and acquisitions

    Reuters
    May 1 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: ** A private equity group made up of Bain Capital LLC and Golden Gate Capital Corp has emerged as the lead contender to buy BMC Software...

    Tags: Sturm Ruger & Company Incorporated, Mergers, Acquisitions and Takeovers, Leveraged Buyouts, United Kingdom, DreamWorks Animation SKG Incorporated

    6. Apr 30, 2013 |Story| Reuters

  6. Serbia gives Galenika sale another month

    Reuters
    BELGRADE, April 30 (Reuters) - Serbia on Tuesday extended for another month a deadline for bids for its indebted state-run drugmaker Galenika Pharmaceuticals, with the U.S.-based unit of Canada's Valeant Pharmaceuticals International so far the only...

    Tags: Drugs and Medicines, Serbia, Belgrade (Serbia), Economy, Business and Finance, Finance

    7. Apr 29, 2013 |Story| Reuters

  7. CANADA STOCKS-TSX may open higher after Italy forms new gov't

    Reuters
    April 29 (Reuters) - Canada's main stock index looked set to open higher, with investors encouraged by the formation of a coalition government in Italy that ended two months of political uncertainty in the troubled region. TOP STORIES * New Italian...

    Tags: Germany, Government, Politics, Economy, Business and Finance, Kinross Gold Corporation

    8. Apr 27, 2013 |Story| Reuters

  8. Merger of drugmakers Valeant, Actavis on hold -source

    Reuters
    April 27 (Reuters) - Talks are on hold to merge drugmakers Valeant Pharmaceuticals International Inc and Actavis Inc in a deal that would have created a healthcare giant, a person familiar with the situation told Reuters on Saturday. A Valeant...
    9. Apr 27, 2013 |Story| Reuters

  9. Drug maker Valeant in talks on $13 bln Actavis buy-source

    Reuters
    April 27 (Reuters) - Canada's largest listed drug maker, Valeant Pharmaceuticals International Inc, is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, a person familiar with the situation told Reuters on Friday night. It is not...

    Tags: Global Expansion, The Wall Street Journal

    10. Apr 26, 2013 |Story| Reuters

  10. Valeant in talks to buy Actavis for over $13 bln -WSJ

    Reuters
    April 26 (Reuters) - Canada's biggest listed drug maker, Valeant Pharmaceuticals International Inc, is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, Wall Street Journal reported, citing people familiar with the matter. The...

    Tags: Global Expansion, The Wall Street Journal

    11. May 3, 2011 |Story| Los Angeles Times
  11. |Story
Original site for Valeant Pharmaceuticals International topic gallery.